Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $38.92MP/E –Yield –
Harvard Apparatus Regenerative Technology r&d expenses
Research and development expenses are spending on new products and technology.
Harvard Apparatus Regenerative Technology's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.87M, up 34.8% year over year. For fiscal 2025 it was $2.65M, up 14.8% from the year before. Over ten years it grew -5.7% a year on average. The highest annual figure on record is $7.60M in fiscal 2016.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65M | +14.8% |
| FY2024 | Dec 31, 2024 | $2.31M | -24.6% |
| FY2023 | Dec 31, 2023 | $3.06M | +75.8% |
| FY2022 | Dec 31, 2022 | $1.74M | +9.4% |
| FY2021 | Dec 31, 2021 | $1.59M | -23.1% |
| FY2020 | Dec 31, 2020 | $2.07M | -57.4% |
| FY2019 | Dec 31, 2019 | $4.85M | +23.9% |
| FY2018 | Dec 31, 2018 | $3.92M | -48.4% |
| FY2017 | Dec 31, 2017 | $7.59M | -0.2% |
| FY2016 | Dec 31, 2016 | $7.60M | +58.9% |
| FY2015 | Dec 31, 2015 | $4.79M | -6.5% |
| FY2014 | Dec 31, 2014 | $5.12M | +12.2% |
| FY2013 | Dec 31, 2013 | $4.56M | +13.3% |
| FY2012 | Dec 31, 2012 | $4.03M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $948.00K | +36.0% |
| Q1 FY2026 | Mar 31, 2026 | $563.00K | -6.3% |
| Q4 FY2025 | Dec 31, 2025 | $700.00K | +158.3% |
| Q3 FY2025 | Sep 30, 2025 | $655.00K | +17.6% |
| Q2 FY2025 | Jun 30, 2025 | $697.00K | +8.6% |
| Q1 FY2025 | Mar 31, 2025 | $601.00K | -28.5% |
| Q4 FY2024 | Dec 31, 2024 | $271.00K | -58.2% |
| Q3 FY2024 | Sep 30, 2024 | $557.00K | +64.3% |
| Q2 FY2024 | Jun 30, 2024 | $642.00K | -59.0% |
| Q1 FY2024 | Mar 31, 2024 | $840.00K | +65.0% |
| Q4 FY2023 | Dec 31, 2023 | $648.00K | -12.9% |
| Q3 FY2023 | Sep 30, 2023 | $339.00K | -8.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.57M | +380.4% |
| Q1 FY2023 | Mar 31, 2023 | $509.00K | +68.0% |
| Q4 FY2022 | Dec 31, 2022 | $744.00K | +30.8% |
| Q3 FY2022 | Sep 30, 2022 | $369.00K | +47.6% |
| Q2 FY2022 | Jun 30, 2022 | $326.00K | +8.7% |
| Q1 FY2022 | Mar 31, 2022 | $303.00K | -35.9% |
| Q4 FY2021 | Dec 31, 2021 | $569.00K | +66.4% |
| Q3 FY2021 | Sep 30, 2021 | $250.00K | -54.4% |
| Q2 FY2021 | Jun 30, 2021 | $300.00K | -44.0% |
| Q1 FY2021 | Mar 31, 2021 | $473.00K | -26.4% |
| Q4 FY2020 | Dec 31, 2020 | $342.00K | -59.5% |
| Q3 FY2020 | Sep 30, 2020 | $548.00K | -65.7% |
| Q2 FY2020 | Jun 30, 2020 | $536.00K | -61.0% |
| Q1 FY2020 | Mar 31, 2020 | $643.00K | -37.8% |
| Q4 FY2019 | Dec 31, 2019 | $845.00K | -26.4% |
| Q3 FY2019 | Sep 30, 2019 | $1.60M | +24.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.38M | +48.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.03M | +87.3% |
| Q4 FY2018 | Dec 31, 2018 | $1.15M | +145.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.29M | -45.5% |
| Q2 FY2018 | Jun 30, 2018 | $928.00K | -65.5% |
| Q1 FY2018 | Mar 31, 2018 | $552.00K | -73.3% |
| Q4 FY2017 | Dec 31, 2017 | $467.00K | -79.9% |
| Q3 FY2017 | Sep 30, 2017 | $2.36M | +6.2% |
| Q2 FY2017 | Jun 30, 2017 | $2.69M | – |
| Q1 FY2017 | Mar 31, 2017 | $2.07M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.32M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.23M | – |
See a number that looks wrong?